301009.SZ(301009.SZ)
301009.SZ
No analyst ratings available
No analyst price targets available for 301009.SZ
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.23B | $1.33B |
| Low | $1.23B | $1.33B |
| High | $1.23B | $1.33B |
| EBITDA Avg | $79M | $86M |
| Low | $79M | $86M |
| High | $79M | $86M |
| EBIT Avg | $19M | $21M |
| Low | $19M | $21M |
| High | $19M | $21M |
| Net Income Avg | $41M | $46M |
| Low | $41M | $46M |
| High | $41M | $46M |
| EPS Avg | $0.16 | $0.18 |
| Low | $0.16 | $0.18 |
| High | $0.16 | $0.18 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q3 2027 | Q2 2028 | Q4 2028 | Q1 2029 | Q2 2029 |
|---|---|---|---|---|---|---|
| Revenue Avg | $322M | $319M | $287M | $286M | $286M | $285M |
| Low | $322M | $319M | $287M | $286M | $286M | $285M |
| High | $322M | $319M | $287M | $286M | $286M | $285M |
| EBITDA Avg | $21M | $21M | $19M | $19M | $18M | $18M |
| Low | $21M | $21M | $19M | $19M | $18M | $18M |
| High | $21M | $21M | $19M | $19M | $18M | $18M |
| EBIT Avg | $5M | $5M | $4M | $4M | $4M | $4M |
| Low | $5M | $5M | $4M | $4M | $4M | $4M |
| High | $5M | $5M | $4M | $4M | $4M | $4M |
| Net Income Avg | $3M | $11M | $13M | $13M | $11M | $8M |
| Low | $3M | $11M | $13M | $13M | $11M | $8M |
| High | $3M | $11M | $13M | $13M | $11M | $8M |
| EPS Avg | $0.01 | $0.04 | $0.05 | $0.05 | $0.04 | $0.03 |
| Low | $0.01 | $0.04 | $0.05 | $0.05 | $0.04 | $0.03 |
| High | $0.01 | $0.04 | $0.05 | $0.05 | $0.04 | $0.03 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |